Nestlé keeps it short and sweet with €500m at 5bp over
Nestlé today returned to the euro bond market for the third time since announcing its $11.85bn acquisition of Pfizer’s infant nutrition business in April. Many investors in Europe are now more hungry for spread than safety, so the €500m deal was more muted than some of Nestlé’s, but it still priced extremely tightly.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts